Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ·Healthcare·Biotechnology
$35.22
-2.15%
Mkt Cap $2.14B
Analyst Ratings
Buy
10
Hold
3
Sell
0
Price Target (25 analysts)
$41.67
Range $32.00 – $52.00
Implied Upside
+18.3%
Consensus $41.67 vs current $35.22
NASDAQ·Healthcare·Biotechnology
$35.22
-2.15%
Mkt Cap $2.14B
Buy
10
Hold
3
Sell
0
Price Target (25 analysts)
$41.67
Range $32.00 – $52.00
+18.3%
Consensus $41.67 vs current $35.22